Yu-Min Ko Selected Research

Chemokines

1/2022

Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Min Ko Research Topics

Disease

10	Chronic Hepatitis C 01/2022 - 07/2016
8	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 07/2016
8	Infections 01/2022 - 06/2017
6	Fibrosis (Cirrhosis) 01/2023 - 10/2011
3	Neoplasms (Cancer) 01/2022 - 10/2011
3	Chronic Hepatitis B 01/2021 - 11/2020
3	Viremia 01/2021 - 01/2021
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 05/2017
2	Hepatitis B 01/2021 - 10/2017
2	Hepatitis C 01/2018 - 06/2017
2	Liver Diseases (Liver Disease) 05/2017 - 07/2016
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Hepatitis D 01/2021
1	Diabetes Mellitus 07/2016
1	Diabetic Nephropathies (Diabetic Nephropathy) 07/2013
1	Hypertrophy 07/2013
1	Breast Neoplasms (Breast Cancer) 10/2011
1	Ischemia 10/2011

Drug/Important Bio-Agent (IBA)

8	Antiviral Agents (Antivirals)IBA 01/2023 - 07/2016
6	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2017
4	Ribavirin (Virazole)FDA LinkGeneric 01/2022 - 06/2017
3	NucleosidesIBA 01/2021 - 11/2020
3	NucleotidesIBA 01/2021 - 11/2020
2	InterferonsIBA 01/2022 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2017
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 10/2017
2	nasIBA 01/2021 - 01/2021
2	micaIBA 05/2017 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 07/2016 - 07/2013
2	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2013 - 10/2011
2	Proteins (Proteins, Gene)FDA Link 07/2013 - 10/2011
1	ChemokinesIBA 01/2022
1	CytokinesIBA 01/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	lenvatinibIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	regorafenibIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	asunaprevirIBA 01/2020
1	daclatasvirIBA 01/2020
1	Vitamin D FDA LinkGeneric 12/2017
1	Peptides (Polypeptides)IBA 05/2017
1	Small Interfering RNA (siRNA)IBA 07/2013
1	Ubiquitin CIBA 07/2013
1	Fibronectins (Fibronectin)IBA 07/2013
1	Cyclin D1IBA 10/2011
1	annonacinIBA 10/2011
1	Estrogen ReceptorsIBA 10/2011
1	Tamoxifen FDA LinkGeneric 10/2011
1	Gefitinib (Iressa)FDA Link 10/2011
1	Phosphotransferases (Kinase)IBA 10/2011
1	ErbB Receptors (EGF Receptor)IBA 10/2011

Therapy/Procedure

10	Therapeutics 01/2023 - 07/2016
1	Salvage Therapy 01/2022